June 26, 2019

Botox and the value of never-ending profits

Abbvie’s bid for Allergan shows that the Botox franchise is impenetrable. The market agrees.

December 06, 2017

Revance data erase frowns for now

June 13, 2013

Can kicked down the road on diabetes drug cancer risks

September 29, 2011

Therapeutic Focus - Diabetic foot ulcer market in need of healing

July 13, 2011

EP Vantage Interview - Medivir mulling deals as hopes for hep C drug build